This topic brief provides an overview of bioprinting technologies capable of fabricating tissue constructs or organ‑like structures for regenerative medicine, drug testing, and personalized therapies. It highlights major scientific advances, material and bio‑ink innovations, and early clinical research pathways. Ethical issues, regulatory barriers, and technological uncertainties are discussed as crucial factors shaping the future adoption of bioprinting in healthcare systems.